This injection is indicated primarily for the treatment of bovine respiratory disease associated with Mannheimia haemolytica,where an anti-inflammatory and anti-pyretic effect is required
Each ml contains
This injection is indicated primarily for the treatment of bovine respiratory disease associated with Mannheimia haemolytica,where an anti-inflammatory and anti-pyretic effect is required. In addition a wide range of organisms including Pasteurellaspp, Arcanobacterium pyogenes, Staphylococcus aureus and certain mycoplasmas are known to be sensitive in vitro to oxytetracycline.
Dosage and Administration:
For deep intramuscular injection to cattle.
The recommended dosage is 1ml per 10kg bodyweight (equivalent to 30mg/kg oxytetracycline and 2mg/kg flunixin meglumine) on a single occasion.
Maximum volume per injection site: 15ml. If concurrent treatment is administered, use a separate injection site.
Use is contraindicated in animals suffering from cardiac, hepatic or renal disease, where there is a possibility of gastrointestinal ulceration or bleeding or where there is hyper sensitivity to the product.
Avoid use in dehydrated, hypovolaemic or hypotensive animals as there is a potential risk of increased renal toxicity.
Do not administer other NSAIDs concurrently or within 24hours of each other.
Concurrent use of potentially nephrotoxic drugs should beavoided. Do not exceed the stated dose or duration of treatment.
Animals must not be slaughtered for human consumption during treatment.
Cattle may be slaughtered for human consumption only after 35 days from the last treatment.
Not for use in cattle producing milk for human consumption.
Tightly sealed and store below 25℃, avoid direct sun lights.